On the basis of the patterns of conserved amino acid sequence, the angioten
sin II type 2 (AT(2)) receptor belongs to the family of serpentine receptor
s, which relay signals from extracellular stimuli to heterotrimeric G prote
ins. However, the AT(2) receptor signal transduction mechanisms are poorly
understood. We have measured AT(2)-triggered activation of purified heterot
rimeric proteins in urea-extracted membranes from cultured COS-7 cells expr
essing the recombinant receptor. This procedure removes contaminating GTP-b
inding proteins without inactivating the serpentine receptor. Binding studi
es using [I-125] angiotensin (Ang) II revealed a single binding site with a
K-d=0.45 and a capacity of 627 fmol/mg protein in the extracted membranes.
The AT(2) receptor caused a rapid activation of alpha(i) and alpha(o), but
not of alpha(q) and alpha(s), as measured by radioactive guanosine 5'-3-O-
(thio)triphosphate (GTP gammaS) binding. Activation required the presence o
f activated receptors, beta gamma, and alpha subunits. As a first step aime
d at developing an in vitro assay to examine AT(2) receptor pharmacology, w
e tested a battery of Ang II-related ligands for their ability to promote A
T(1) or AT(2) receptor-catalyzed G(i) activation. Two proteolytic fragments
of Ang II, Ang III and Ang1-7, also promoted activation of alpha(i) throug
h the AT(2) receptor. Furthermore, we found that [Sar(1),Ala(8)]Ang II is a
n antagonist for both AT(1) and AT(2) receptors and that CPG42112 behaves a
s a partial agonist for the AT(2) receptor. In combination with previous ob
servations, these results show that the AT(2) receptor is fully capable of
activating G(i) and provides a new tool for exploring AT(2) receptor pharma
cology and interactions with G-protein trimers.